Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Palliative Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Nekolaichuk, C.
Right arrow Articles by Beaumont, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nekolaichuk, C.
Right arrow Articles by Beaumont, C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

research-article

The Edmonton Symptom Assessment System: a 15-year retrospective review of validation studies (1991–2006)

Cheryl Nekolaichuk

Division of Palliative Care Medicine, Department of Oncology, University of Alberta, Edmonton, Alberta, Canada

Sharon Watanabe

Division of Palliative Care Medicine, Department of Oncology, University of Alberta, Edmonton, Alberta, Canada

Crystal Beaumont

Division of Palliative Care Medicine, Department of Oncology, University of Alberta, Edmonton, Alberta, Canada

Introduction: The purpose of this review was to identify and critique validation studies focusing on the Edmonton Symptom Assessment System (ESAS), a commonly used symptom assessment tool for advanced cancer and palliative patients. Methods: Using a comprehensive literature search, the authors identified and screened 87 publications. Thirteen articles were selected for in-depth review, based on the following inclusion criteria: psychometric studies with a primary focus on the ESAS, 1991–2006 publication dates and peer-reviewed English language publications. Results: Most studies involved cancer patients (n = 11). The ESAS format varied across studies, in terms of scale format, item number, item selection and language. Studies focused on gathering reliability estimates (n = 8), content validity evidence (n = 1), concurrent validity evidence (n = 5), predictive validity evidence (n = 1), and sensitivity and/or specificity (n = 3). None of these studies involved patients’ perspectives as a source of validity evidence. Discussion: The use of varying instrument formats and limited psychometric evidence support the need for further ESAS validation studies, including the involvement of patients.

Key Words: Edmonton Symptom Assessment System • ESAS • instrument development • literature review • psychometrics • validation studies

Palliative Medicine, Vol. 22, No. 2, 111-122 (2008)
DOI: 10.1177/0269216307087659
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 In VivoHome page
G. FIORENTINI, C. ALIBERTI, A. DEL CONTE, M. TILLI, S. ROSSI, P. BALLARDINI, G. TURRISI, and G. BENEA
Intra-arterial Hepatic Chemoembolization (TACE) of Liver Metastases from Ocular Melanoma with Slow-release Irinotecan-eluting Beads. Early Results of a Phase II Clinical Study
In Vivo, January 1, 2009; 23(1): 131 - 137.
[Abstract] [Full Text] [PDF]